NCT01614093 Effects of Intranasal Oxytocin on Satiety Signaling in People With Schizophrenia Status COMPLETED Phase PHASE4
NCT01611337 Insight in Persons Presenting Schizophrenia or Related Troubles During Hospitalization in Psychiatry Status COMPLETED Phase NA
NCT01609153 Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy Status COMPLETED Phase PHASE4
NCT01607840 Effects of Transcranial Direct Current Stimulation in Individuals With Schizophrenia Status COMPLETED Phase NA
NCT01606254 A Pharmacokinetic and Safety Study of Paliperidone Palmitate (JNS010) in Participants With Schizophrenia Status COMPLETED Phase PHASE2
NCT01606228 A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT01602263 Transcranial Direct Current Stimulation (tDCS) and Cognitive Processing Status COMPLETED Phase N/A
NCT01602029 Randomized Double Blind Placebo Control Study in Patients with Schizophrenia Status COMPLETED Phase PHASE2
NCT01598220 Computer Assisted Cognitive Remediation Program in Schizophrenia Status COMPLETED Phase NA
NCT01596608 Magnetic Seizure Therapy (MST) for Treatment Resistant Depression, Schizophrenia, and Obsessive Compulsive Disorder Status COMPLETED Phase NA
NCT01595503 Transcranial Magnetic Stimulation for the Treatment of Auditory Hallucinations in Schizophrenia Status TERMINATED Phase NA
NCT01593774 Melatonin for Prevention of Metabolic Side Effects of Olanzapine Status COMPLETED Phase PHASE2
NCT01592201 A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic Drug Status TERMINATED Phase PHASE4
NCT01592110 A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia Status COMPLETED Phase PHASE1
NCT01584466 Long Acting Paliperidone in Dually Diagnosed People With Schizophrenia: An Open-label Pilot Study Status WITHDRAWN Phase NA